Does aspirin increase the risk of age-related macular degeneration?

Author： Chong Elaine W   Guymer Robyn H   Robman Liubov D  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.6, 2014-06, pp. : 691-693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?

By Christen William G   Chew Emily Y  

Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. : 421-429

Informa Healthcare

Access to resources Recommend Favorite

Aspirin and age-related macular degeneration: positives versus negatives

By Nowak Jerzy Z  

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 687-690

Informa Healthcare

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration

By Schmier Jordana K.   Jones Mechelle L.   Halpern Michael T.  

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 319-334

Adis International

Access to resources Recommend Favorite

A Preliminary Benefit-Risk Assessment of Verteporfin in Age-Related Macular Degeneration

By Wickens Jason   Blinder Kevin J.  

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 189-199

Adis International

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A.   Keating Gillian M.  

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite